DISPENSATION IN COMMUNITY PHARMACY TO PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS TREATED WITH BISPHOSPHONATES OR STRONTIUM RANELATE

被引:0
|
作者
Moranta Ribas, Francesc [1 ]
Llull Vila, Rosa [1 ]
Oliver Oliver, Bartomeu [1 ]
机构
[1] Farmaceut Comunitarios Islas Baleares, Palma De Mallorca, Illes Balears, Spain
来源
FARMACEUTICOS COMUNITARIOS | 2011年 / 3卷 / 03期
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:93 / 98
页数:6
相关论文
共 50 条
  • [21] Clinical effects of strontium ranelate in women with postmenopausal osteoporosis
    Pierre D. Delmas
    Osteoporosis International, 2005, 16 : S16 - S19
  • [22] Strontium ranelate - Does it affect the management of postmenopausal osteoporosis?
    Winzenberg, Tania
    Powell, Sandi
    Jones, Graerne
    AUSTRALIAN FAMILY PHYSICIAN, 2007, 36 (08) : 631 - 632
  • [23] Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
    Cesareo, Roberto
    Napolitano, Clemente
    Lozzino, Mario
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2010, 2 : 1 - 6
  • [24] The Effects of Strontium Ranelate in Asian Women with Postmenopausal Osteoporosis
    J. S. Hwang
    J. F. Chen
    T. S. Yang
    D. J. Wu
    K. S. Tsai
    C. Ho
    C. H. Wu
    S. L. Su
    C. J. Wang
    S. T. Tu
    Calcified Tissue International, 2008, 83 : 308 - 314
  • [25] Impact of Treatments for Postmenopausal Osteoporosis (Bisphosphonates, Parathyroid Hormone, Strontium Ranelate, and Denosumab) on Bone Quality: A Systematic Review
    Gallacher, S. J.
    Dixon, T.
    CALCIFIED TISSUE INTERNATIONAL, 2010, 87 (06) : 469 - 484
  • [26] Impact of Treatments for Postmenopausal Osteoporosis (Bisphosphonates, Parathyroid Hormone, Strontium Ranelate, and Denosumab) on Bone Quality: A Systematic Review
    S. J. Gallacher
    T. Dixon
    Calcified Tissue International, 2010, 87 : 469 - 484
  • [27] Strontium Ranelate A Review of its Use in the Treatment of Postmenopausal Osteoporosis
    Deeks, Emma D.
    Dhillon, Sohita
    DRUGS, 2010, 70 (06) : 733 - 759
  • [28] Strontium ranelate and non-vertebral fracture in postmenopausal osteoporosis
    Callejas Rubio, Jose Luis
    Lopez Perez, Lourdes
    Sanchez Cano, Daniel
    Ortego Centeno, Norberto
    MEDICINA CLINICA, 2006, 127 (07): : 279 - 279
  • [29] EFFECT OF STRONTIUM RANELATE ON SERUM OSTEOPROTEGERIN IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS TREATED OVER THREE YEARS
    Collette, J.
    Bruyere, O.
    Vanoverberghe, M.
    Reginster, J.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 311 - 312
  • [30] Permanganometry for the Determination of Strontium and Strontium Ranelate in Pharmaceutical Formulation for the Treatment of Postmenopausal Osteoporosis
    Povoa, Mayara N.
    de Carvalho, Renata C.
    Pereira Netto, Annibal D.
    Marques, Flavia F. C.
    REVISTA VIRTUAL DE QUIMICA, 2015, 7 (06) : 2124 - 2138